BTMD
biote Corp
NASDAQ: BTMD · HEALTHCARE · MEDICAL CARE FACILITIES
$2.22
+0.00% today
Updated 2026-04-30
Market cap
$73.07M
P/E ratio
3.08
P/S ratio
0.38x
EPS (TTM)
$0.74
Dividend yield
—
52W range
$1 – $5
Volume
0.3M
biote Corp (BTMD) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $109.98M | $116.57M | $139.40M | $164.96M | $185.36M | $197.19M | $192.22M |
| Revenue growth (YoY) | — | +6.0% | +19.6% | +18.3% | +12.4% | +6.4% | -2.5% |
| Cost of revenue | $43.56M | $44.93M | $48.82M | $54.58M | $57.88M | $58.13M | $54.86M |
| Gross profit | $66.41M | $71.64M | $90.58M | $110.38M | $127.48M | $139.06M | $137.36M |
| Gross margin | 60.4% | 61.5% | 65.0% | 66.9% | 68.8% | 70.5% | 71.5% |
| R&D | — | — | — | — | — | — | — |
| SG&A | $32.03M | $33.02M | $49.05M | $165.50M | $93.42M | $107.45M | $101.81M |
| Operating income | $23.53M | $31.78M | $34.56M | $-60.72M | $28.66M | $31.61M | $35.55M |
| Operating margin | 21.4% | 27.3% | 24.8% | -36.8% | 15.5% | 16.0% | 18.5% |
| EBITDA | $24.29M | $32.91M | $35.98M | $7.96M | $39.54M | $15.59M | $39.22M |
| EBITDA margin | 22.1% | 28.2% | 25.8% | 4.8% | 21.3% | 7.9% | 20.4% |
| EBIT | $23.46M | $31.78M | $34.58M | $5.76M | $38.74M | $12.02M | $35.55M |
| Interest expense | $2.08M | $2.42M | $1.67M | $4.05M | $6.36M | $11.00M | $10.96M |
| Income tax | $93000.00 | $189000.00 | $286000.00 | $388000.00 | $2.68M | $970000.00 | — |
| Effective tax rate | 0.4% | 0.6% | 0.9% | -66.8% | 44.7% | 23.5% | 0.0% |
| Net income | $21.29M | $29.16M | $32.62M | $-969000.00 | $3.32M | $3.16M | $27.05M |
| Net income growth (YoY) | — | +37.0% | +11.9% | -103.0% | +442.2% | -4.8% | +756.7% |
| Profit margin | 19.4% | 25.0% | 23.4% | -0.6% | 1.8% | 1.6% | 14.1% |